Clear Investment Research’s AbbVie ABBV Stock Holding History

Clear Investment Research’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$60.6K	Buy	+279	New	+$61.9K	0.09%	99
2025 Q4	–	Sell	-278	Closed	-$64.5K	–	52
2025 Q3	$64.5K	Buy	278 +25	+10%	+$5.09K	0.09%	105
2025 Q2	$47.1K	Hold	253	–	–	0.06%	114
2025 Q1	$53.1K	Hold	253	–	–	0.07%	106
2024 Q4	$45.1K	Hold	253	–	–	0.06%	112
2024 Q3	$50.1K	Hold	253	–	–	0.07%	106
2024 Q2	$43.5K	Buy	253 +2	+0.8%	+$331	0.06%	105
2024 Q1	$45.7K	Sell	251 -59	-19%	-$10.2K	0.06%	105
2023 Q4	$48K	Buy	+310	New	+$45.2K	0.07%	107
2019 Q4	–	Sell	-10	Closed	-$1K	–	109
2019 Q3	$1K	Buy	10 +3	+43%	+$206	﹤0.01%	132
2019 Q2	$1K	Hold	7	–	–	﹤0.01%	132
2019 Q1	$1K	Hold	7	–	–	﹤0.01%	129
2018 Q4	$1K	Hold	7	–	–	﹤0.01%	123
2018 Q3	$1K	Buy	+7	New	+$664	﹤0.01%	133

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clear Investment Research's ABBV Position: Q1 2026 in Review

Clear Investment Research opened a new position in AbbVie (ABBV) in Q1 2026: 279 shares worth $60.6K. The stake represents 0.09% of the portfolio and ranks #99 among its holdings. This is a return to the name: Clear Investment Research previously reported a position in ABBV as recently as Q3 2025.

Clear Investment Research first reported a position in ABBV in Q3 2018 and has held it in 14 quarters since. The position peaked at $64.5K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Clear Investment Research held 279 shares of AbbVie worth $60.6K as of Q1 2026.
AbbVie was a new Clear Investment Research position in Q1 2026.
AbbVie made up 0.09% of Clear Investment Research's portfolio in Q1 2026, its #99 holding.
Clear Investment Research first reported a position in AbbVie in Q3 2018 and has held it in 14 quarters since.
Clear Investment Research's AbbVie position peaked at $64.5K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Clear Investment Research's 13F filing for Q1 2026, filed 4 May 2026.